Dr. Lal PathLabs Q2 FY27 Revenue Up 19.6% to ₹874 Cr

Dr. Lal PathLabs Limited announced its unaudited financial results for the quarter and half-year ended September 30, 2026. For Q2 FY27, the company reported a consolidated revenue of ₹874 Cr, a 19.6% increase year-on-year. EBITDA grew by 25.1% to ₹280 Cr with a margin of 32.1%, and Profit After Tax (PAT) rose by 27.5% to ₹194 Cr, achieving a margin of 22.2%. For the half-year ended FY27, revenue increased by 19.4% to ₹1,672 Cr, EBITDA by 26.7% to ₹528 Cr, and PAT by 27.3% to ₹364 Cr. The company also declared an interim dividend of 50%, or ₹5 per share. Cash and cash equivalents stood at ₹1,746 Cr as of September 30, 2026.